Facial feminization with injectables: what to assess

Facial feminization is the set of changes that brings the face closer to features socially read as feminine. The demand comes mostly from trans women and travestis, but also from nonbinary people and cis women who feel their face looks "heavy" or "masculine". With injectables, orofacial harmonization (HOF) can redistribute volume and soften contours; it cannot change bone.

This page organizes the assessment, the limits, and the welcoming approach, at a review level. Volumes, technique, and product choice are decisions for the licensed professional, according to the rules of their professional council in Brazil. For the opposite path, see masculine orofacial harmonization.

How do you welcome the patient from the first contact?

Care starts before the facial assessment. Many trans patients report bad experiences in health services, and the first appointment decides whether she comes back.

• Use the chosen name and the pronoun the patient indicates, at every moment: front desk, intake form, patient record, messages, and quote. Have a field for chosen name on the form.
• Ask, do not assume. "What would you like us to call you?" and "what bothers you most about your face?" open the conversation without labels.
• Separate her goal from a standard. Feminizing is not following a reference face; it is reaching the face she recognizes as her own.
• Train the team. A front desk that gets the name wrong destroys trust before she reaches the chair.

Which features tend to be read as feminine or masculine?

These are average tendencies, not rules, and there is enormous variation among people of any gender. Still, they guide the assessment.

Assess from the front, in profile, and in three-quarter view, using the facial assessment by thirds. The upper and lower thirds tend to concentrate the bony features; the middle third and the lips concentrate what injectables reach best.

What can filler and toxin do?

At a review level, the most commonly cited approaches are:

• Cheek filler, to enhance the anterior, high projection of the cheekbone, which draws the eye away from the lower third.
• Temple filler, to soften the lateral concavity and add curve to the upper contour.
• Lip filler, for volume and definition, respecting lip proportion and face size.
• Botulinum toxin in the masseter, when the muscle is hypertrophic, to reduce the width of the lower third over weeks.
• Botulinum toxin in the brow, for a discreet lift of the tail in those with a good indication.
• Chin adjustment, with care: increasing chin width masculinizes. The goal is the design, not the volume.

What tends to be avoided: adding volume to the jaw angle and widening the lower contour, which are precisely the strategies of masculinized faces. In cis women with a square face, the logic is similar; see square face: assessment.

Where are the limits of injectables?

A forehead with bony prominence, a wide jaw angle, a large bony chin, the nose, and the thyroid cartilage are bony or cartilaginous structures. Injectables do not reduce any of them. That is what facial feminization surgery is for, performed by surgical teams, with their own assessment.

The role of HOF can be complementary: before, after, or instead of surgery, depending on the patient's choice, access, and indication. Being honest about the limit prevents overtreatment to compensate for what only surgery would change.

How do you organize the plan in stages?

Hypothetical example of a sequence, to be adjusted to each face and at the discretion of the licensed professional:

Staging lets you stop at the point where the patient recognizes herself, without accumulating volume. To structure the quote by phases, see the staged plan.

What about hormone therapy?

Estrogen changes facial fat distribution and skin texture over months, and can soften the face on its own. That is why many professionals prefer to plan volumes when the patient is in a more stable phase of hormone therapy and to review the plan when the face changes. It is not up to HOF to guide hormone therapy: ask whoever follows it and keep in touch when needed.

Also record the medications in use, because some interfere with bleeding and healing. See anticoagulants and injectable procedures.

Which risks and precautions deserve attention?

The risks are the same as for each procedure: swelling, bruising, asymmetry, nodules, and, with fillers, vascular occlusion. The temples and lips are in vascular-risk areas, and hyaluronidase must be available when hyaluronic acid is used. See safety and complications: overview.

There is also a specific concern: expectations. Gender dysphoria is not a dysmorphic disorder, but some patients, like anyone, may have expectations that are hard to reach with injectables. Listening carefully, showing the limit, and agreeing on stages is the rule. When there is disproportionate concern about a minimal flaw, see body dysmorphic disorder in HOF.

And in Harmy?

Show the illustrative simulation as support for the conversation, never as a promise. To handle that moment, see how to present the before and after in the consultation.

Assessment checklist for feminization with injectables

1. Chosen name and pronoun recorded and used by the whole team.
2. Patient's goal described in her own words.
3. Hormone therapy, duration of use, and who follows it recorded.
4. Previous procedures and materials investigated.
5. Bony features separated from volume and soft-tissue features.
6. Staged plan, prioritizing proportion over total volume.
7. Limits of injectables explained, with referral when it makes sense.
8. Specific informed consent, with the risks of each area.
9. Standardized photos and follow-up scheduled.